glucose metabolism
Do PCSK9 inhibitors increase new-onset diabetes? Another meta-analysis
A new meta-analysis involving more than 26,000 patients reports no increase in new-onset diabetes and no impact on glucose metabolism with PCSK9 inhibitor treatment. The authors performed a comprehensive medical literature to identify 18 randomized controlled studies with 26,123 patients without diabetes at study baseline….
read more »Posted on 9 February 2018 |
Posted in News
